Viatris Inc. (VTRS) CEO Michael Goettler Presents at 4th Annual Evercore ISI HealthCONx Virtual Brokers Conference (Transcript)Seeking Alpha • 12/01/21
Viatris Wins Federal Circuit Court Appeal Upholding District Court Decision Invalidating Biogen's Tecfidera® PatentPRNewsWire • 12/01/21
Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) InjectionPRNewsWire • 11/16/21
Viatris Donates $1 Million as Founding Champion to New Orleans-based SBP's "Got Your Back" fund in Support of Housing Solutions for Veterans in Disaster-Impacted CommunitiesPRNewsWire • 11/11/21
Viatris Inc. (VTRS) CEO Michael Goettler on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/08/21
Viatris Reports Strong Third Quarter Results, Raises 2021 Financial Guidance and Announces Virtual Investor Event on January 7, 2022PRNewsWire • 11/08/21